193 related articles for article (PubMed ID: 11744100)
1. Neuroactive steroids and peripheral myelin proteins.
Magnaghi V; Cavarretta I; Galbiati M; Martini L; Melcangi RC
Brain Res Brain Res Rev; 2001 Nov; 37(1-3):360-71. PubMed ID: 11744100
[TBL] [Abstract][Full Text] [Related]
2. Effects of neuroactive steroids on myelin of peripheral nervous system.
Melcangi RC; Ballabio M; Cavarretta I; Gonzalez LC; Leonelli E; Veiga S; Martini L; Magnaghi V
J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):323-7. PubMed ID: 12943718
[TBL] [Abstract][Full Text] [Related]
3. The action of steroid hormones on peripheral myelin proteins: a possible new tool for the rebuilding of myelin?
Melcangi RC; Magnaghi V; Galbiati M; Ghelarducci B; Sebastiani L; Martini L
J Neurocytol; 2000; 29(5-6):327-39. PubMed ID: 11424949
[TBL] [Abstract][Full Text] [Related]
4. Actions of progesterone and its 5alpha-reduced metabolites on the major proteins of the myelin of the peripheral nervous system.
Martini L; Magnaghi V; Melcangi RC
Steroids; 2003 Nov; 68(10-13):825-9. PubMed ID: 14667974
[TBL] [Abstract][Full Text] [Related]
5. The synthesis of glycoprotein Po and peripheral myelin protein 22 in sciatic nerve of male rats is modulated by testosterone metabolites.
Magnaghi V; Ballabio M; Gonzalez LC; Leonelli E; Motta M; Melcangi RC
Brain Res Mol Brain Res; 2004 Jul; 126(1):67-73. PubMed ID: 15207917
[TBL] [Abstract][Full Text] [Related]
6. Peripheral nerves: a target for the action of neuroactive steroids.
Melcangi RC; Cavarretta IT; Ballabio M; Leonelli E; Schenone A; Azcoitia I; Miguel Garcia-Segura L; Magnaghi V
Brain Res Brain Res Rev; 2005 Apr; 48(2):328-38. PubMed ID: 15850671
[TBL] [Abstract][Full Text] [Related]
7. Neuroactive steroids influence peripheral myelination: a promising opportunity for preventing or treating age-dependent dysfunctions of peripheral nerves.
Melcangi RC; Azcoitia I; Ballabio M; Cavarretta I; Gonzalez LC; Leonelli E; Magnaghi V; Veiga S; Garcia-Segura LM
Prog Neurobiol; 2003 Sep; 71(1):57-66. PubMed ID: 14611868
[TBL] [Abstract][Full Text] [Related]
8. Sex-dimorphic effects of progesterone and its reduced metabolites on gene expression of myelin proteins by rat Schwann cells.
Magnaghi V; Veiga S; Ballabio M; Gonzalez LC; Garcia-Segura LM; Melcangi RC
J Peripher Nerv Syst; 2006 Jun; 11(2):111-8. PubMed ID: 16787508
[TBL] [Abstract][Full Text] [Related]
9. Neuroactive Steroid Levels in a transgenic rat model of CMT1A Neuropathy.
Caruso D; Scurati S; Roglio I; Nobbio L; Schenone A; Melcangi RC
J Mol Neurosci; 2008 Mar; 34(3):249-53. PubMed ID: 18193358
[TBL] [Abstract][Full Text] [Related]
10. Progesterone derivatives are able to influence peripheral myelin protein 22 and P0 gene expression: possible mechanisms of action.
Melcangi RC; Magnaghi V; Cavarretta I; Zucchi I; Bovolin P; D'Urso D; Martini L
J Neurosci Res; 1999 May; 56(4):349-57. PubMed ID: 10340743
[TBL] [Abstract][Full Text] [Related]
11. Steroid effects on the gene expression of peripheral myelin proteins.
Melcangi RC; Magnaghi V; Galbiati M; Martini L
Horm Behav; 2001 Sep; 40(2):210-4. PubMed ID: 11534984
[TBL] [Abstract][Full Text] [Related]
12. Po gene expression is modulated by androgens in the sciatic nerve of adult male rats.
Magnaghi V; Cavarretta I; Zucchi I; Susani L; Rupprecht R; Hermann B; Martini L; Melcangi RC
Brain Res Mol Brain Res; 1999 Jun; 70(1):36-44. PubMed ID: 10381541
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of neuroactive steroid levels by liquid chromatography-tandem mass spectrometry in central and peripheral nervous system: effect of diabetes.
Caruso D; Scurati S; Maschi O; De Angelis L; Roglio I; Giatti S; Garcia-Segura LM; Melcangi RC
Neurochem Int; 2008; 52(4-5):560-8. PubMed ID: 17686551
[TBL] [Abstract][Full Text] [Related]
14. Age-induced decrease of glycoprotein Po and myelin basic protein gene expression in the rat sciatic nerve. Repair by steroid derivatives.
Melcangi RC; Magnaghi V; Cavarretta I; Martini L; Piva F
Neuroscience; 1998 Jul; 85(2):569-78. PubMed ID: 9622253
[TBL] [Abstract][Full Text] [Related]
15. Aging in peripheral nerves: regulation of myelin protein genes by steroid hormones.
Melcangi RC; Magnaghi V; Martini L
Prog Neurobiol; 2000 Feb; 60(3):291-308. PubMed ID: 10658644
[TBL] [Abstract][Full Text] [Related]
16. GABA receptor-mediated effects in the peripheral nervous system: A cross-interaction with neuroactive steroids.
Magnaghi V; Ballabio M; Consoli A; Lambert JJ; Roglio I; Melcangi RC
J Mol Neurosci; 2006; 28(1):89-102. PubMed ID: 16632878
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A).
Sereda MW; Meyer zu Hörste G; Suter U; Uzma N; Nave KA
Nat Med; 2003 Dec; 9(12):1533-7. PubMed ID: 14608378
[TBL] [Abstract][Full Text] [Related]
18. Progesterone stimulates the activity of the promoters of peripheral myelin protein-22 and protein zero genes in Schwann cells.
Désarnaud F; Do Thi AN; Brown AM; Lemke G; Suter U; Baulieu EE; Schumacher M
J Neurochem; 1998 Oct; 71(4):1765-8. PubMed ID: 9751213
[TBL] [Abstract][Full Text] [Related]
19. Neuroactive steroids and peripheral neuropathy.
Roglio I; Giatti S; Pesaresi M; Bianchi R; Cavaletti G; Lauria G; Garcia-Segura LM; Melcangi RC
Brain Res Rev; 2008 Mar; 57(2):460-9. PubMed ID: 17543391
[TBL] [Abstract][Full Text] [Related]
20. The alpha-chemokine CXCL14 is up-regulated in the sciatic nerve of a mouse model of Charcot-Marie-Tooth disease type 1A and alters myelin gene expression in cultured Schwann cells.
Barbaria EM; Kohl B; Buhren BA; Hasenpusch-Theil K; Kruse F; Küry P; Martini R; Müller HW
Neurobiol Dis; 2009 Mar; 33(3):448-58. PubMed ID: 19111616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
